Adenine
CAS 73-24-5
Adenine (CAS 73-24-5) is a Phase 3 pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 29912.828169014083 nM | 71 | - |
| - | GI50 | 119423.49224137931 nM | 58 | - |
| - | IC50 | 412194.162 nM | 9 | - |
| - | Potency | 32402.787500000002 nM | 8 | - |
| - | Ki | 2814.2599999999998 nM | 5 | - |
| Xanthine dehydrogenase/oxidase Enzyme |
IC50 | 4.96 | - | Homo sapiens |
| Leucine-rich repeat serine/threonine-protein kinase 2 Kinase |
Ki | 5.17 | - | Homo sapiens |
| Phosphatidylinositol 4-kinase, PI4K Kinase |
Ki | 4.07 | - | Homo sapiens |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Adenine used for in pharmaceutical contexts?
Adenine (CAS 73-24-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Adenine?
No adverse-event association or SIDER side-effect rows are rendered for Adenine in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Adenine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for ADENINE with EU status "permitted".
What clinical phase is Adenine in?
Adenine is rendered with ChEMBL max phase 3.
What bioactivity targets are documented for Adenine?
Adenine has 8 bioactivity rows in this page query. Rendered target entries include Xanthine dehydrogenase/oxidase, Leucine-rich repeat serine/threonine-protein kinase 2, Phosphatidylinositol 4-kinase, PI4K.